BNTC Benitec Biopharma Inc.
$8.85▲ +1.96%
Healthcare
Other
Volume 77.0K
Avg Volume (10D) 175.1K
Key Metrics & Fundamentals
Market Cap
$308.77M
P/E Ratio
–
Div Yield
0.00%
52W Range
8.00 - 16.68
% vs 50 MA
-18.48%
% vs 200 MA
-25.11%
RSI-14
41.4
MACD Histogram
+0.1200
Beta (1Y vs SPY)
1.56
Free Cash Flow
-$5.02M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$14.31M
COGS
–
Operating Exp
$14.43M
Operating Income
-$14.43M
EBIT
-$14.43M
Pretax Income
-$12.81M
Net Income
-$12.81M
Price & Volume History
Loading chart…
Recent News

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301
GlobeNewswire · Oct 28, 2026 8:00 AM ET
Raymond James Initiates Coverage on Benitec Biopharma With Outperform Raring, $14 PT
MT Newswires · Oct 23, 2026 7:26 AM ET

Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
GlobeNewswire · Oct 5, 2026 8:00 AM ET

After Plunging 23.9% in 4 Weeks, Here's Why the Trend Might Reverse for Benitec Biopharma (BNTC)
Zacks · Sep 25, 2026 8:35 AM ET
Wedbush Lifts Price Target on Benitec Biopharma to $17 From $16, Keeps Outperform Rating
MT Newswires · Sep 15, 2026 6:48 AM ET
Benitec Biopharma Files $200 Million Shelf Registration
MT Newswires · Sep 14, 2026 5:47 PM ET

Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
GlobeNewswire · Sep 14, 2026 4:00 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BNTC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.